NEW ORLEANS – A couple has filed suit against several pharmaceutical companies alleging a drug harmed the husband.
David Rowell and Rebecca Rowell filed a complaint on May 27 in the U.S. District Court for the Eastern District of Louisiana against
Janssen Research & Development LLC, Janssen Ortho LLC, Janssen Pharmaceuticals Inc., Bayer Healthcare Pharmaceuticals Inc., et al.
alleging negligent misrepresentation, fraudulent concealment and other counts.
According to the complaint, the plaintiffs allege that plaintiff David Rowell used Xarelto in or around June 19, 2015, until approximately June 29, 2015. As a result of using it, he claims he was caused to suffer from life-threatening bleeding, as well as other severe and personal injuries, which are permanent and lasting in nature. They allege they have suffered and incurred damages, including medical expenses and other economic and non-economic damages.
The plaintiffs holds the defendants responsible because the defendants allegedly designed, researched, manufactured, tested, advertised, promoted, marketed, distributed and sold Xarelto; failed to properly investigate, research, study and define the safety of the drug's profile; failed to adequately test it or provide adequate warnings; failed to disclose the need for dose adjustments; and failed to provide adequate instructions on the drug's use.
The plaintiffs request a trial by jury and seek compensatory damages in excess of the jurisdictional amount, prejudgment and post-judgment interest, reasonable attorneys’ fees, costs of these proceedings and such other and further relief as the court deems just and proper. They are represented by Patrick A. Salvi II and Andrew J. Burkavage of Salvi, Schostok & Pritchard PC in Chicago, Illinois.
U.S. District Court for the Eastern District of Louisiana Case number 2:16-cv-07281